Dyadic International, Inc.

Company Listings from SPi: Dyadic International, Inc.

You are here: Home >> SPi Company Listings >> Dyadic International, Inc.

Patented technologies to discover, develop, manufacture and sell enzymes and other proteins for bioenergy, bio-based chemical, biopharmaceutical and industrial

 

Dyadic International, Inc.

Investor Relations: Dyadic International, Inc., Michael Faby, Chief Financial Officer, Phone: 561-743-8333, Email: mfaby@dyadic.com

Website:
http://www.dyadic.com

Search for other references to "dyadic" on SPi News

Latest Dyadic International, Inc. News

Dyadic Announces Analyst Coverage Initiated by Zacks Small-Cap Research JUPITER, Fla., Oct. 16, 2018 (GLOBE NEWSWIRE) -- Dyadic International, Inc. (“Dyadic”) (OTCQX: DYAI), a global biotechnology company focused on further improving and applying...... 13:30 GMT Tuesday 16th October 2018

Dyadic International Announces Research Collaboration with Sanofi-Aventis JUPITER, Fla., Sept. 07, 2018 (GLOBE NEWSWIRE) -- Dyadic International, Inc. (“Dyadic”) (OTCQX: DYAI), a global biotechnology company focused on further improving and applyin...... 16:18 GMT Friday 7th September 2018

Dyadic International Reports Second Quarter 2018 Financial Results and Extension of Stock Repurchase Program JUPITER, Fla., Aug. 09, 2018 (GLOBE NEWSWIRE) -- Dyadic International, Inc. (“Dyadic”) (OTCQX: DYAI), a global biotechnology company focused on further improving and applying...... 21:00 GMT Thursday 9th August 2018

Dyadic International to Announce Second Quarter 2018 Financial Results and Host Conference Call on Thursday, August 9, 2018 JUPITER, Fla., July 26, 2018 (GLOBE NEWSWIRE) -- Dyadic International, Inc. (“Dyadic”) (OTCQX:DYAI), a global biotechnology company focused on further improving and applying...... 21:30 GMT Thursday 26th July 2018

Dyadic International Improves Monoclonal Antibody (mAb) Productivity Utilizing C1 Gene Expression Platform to Manufacture Biologics JUPITER, Fla., June 18, 2018 (GLOBE NEWSWIRE) -- Dyadic International, Inc. (“Dyadic”) (OTCQX:DYAI), a global biotechnology company focused on further improving and applying...... 14:50 GMT Monday 18th June 2018

Dyadic International Reports First Quarter 2018 Financial Results JUPITER, Fla., May 10, 2018 (GLOBE NEWSWIRE) -- Dyadic International, Inc. (“Dyadic”) (OTCQX:DYAI), a global biotechnology company focused on further improving and applying i...... 21:30 GMT Thursday 10th May 2018

Dyadic International to Announce First Quarter 2018 Financial Results and Host Conference Call on Thursday May 10, 2018 JUPITER, Fla., April 25, 2018 (GLOBE NEWSWIRE) -- Dyadic International, Inc. (“Dyadic”) (OTCQX:DYAI), a global biotechnology company focused on further improving and applying...... 21:30 GMT Wednesday 25th April 2018

Dyadic International Announces 2017 Year End Results and Recent Developments JUPITER, Fla., March 27, 2018 (GLOBE NEWSWIRE) -- Dyadic International, Inc. (“Dyadic”) (OTCQX:DYAI), a global biotechnology company focused on further improving and applying...... 21:30 GMT Tuesday 27th March 2018

Dyadic International Appoints Chief Accounting Officer JUPITER, Fla., March 15, 2018 (GLOBE NEWSWIRE) -- Dyadic International, Inc. (“Dyadic”) (OTCQX:DYAI), today announced that Chief Financial Officer Thomas L. Dubinski
 will...... 20:30 GMT Thursday 15th March 2018

Dyadic International to Announce Year End 2017 Financial Results and Host Conference Call on Tuesday March 27, 2018 JUPITER, Fla., March 13, 2018 (GLOBE NEWSWIRE) -- Dyadic International, Inc. (“Dyadic”) (OTCQX:DYAI), a global biotechnology company focused on further improving and applying...... 20:30 GMT Tuesday 13th March 2018

Buy Dyadic International, Inc.
Market Reports
from SPi

SPi News is published by Sector Publishing Intelligence Ltd.
© Sector Publishing Intelligence Ltd 2018. [Admin Only]
 
Sector Publishing Intelligence Ltd.
Agriculture House, Acland Road, DORCHESTER, Dorset DT1 1EF United Kingdom
Registered in England and Wales number 0751938.
 
Privacy Policy | Terms and Conditions | Contact Us